Rapid Micro Biosystems Inc. (RPID) Business Payback Period

Corporate emblem and logo of Rapid Micro (RPID)

Strict regulatory oversight guarantees Rapid Micro Biosystems (RPID) long-term revenue from the sale of consumables. This daily price action for securities with the -0.70 indicator accompanies the company during a period of reduced spending by pharmaceutical laboratories, which is depleting its reserves. Meanwhile, the business is optimizing costs by outsourcing component production to external contractors and utilizing third-party logistics for reagent delivery.

RPID: Rapid Micro Biosystems, Inc. P/E Multiple 07/04/2022 - 11/12/2026

Analytical breakdowns for Rapid Micro Biosystems Inc. (RPID)

- market price and analyst price targets:
Market Price Rapid Micro|RPID - Price Target Chart
- market capitalization details:
Market Capitalization Rapid Micro Biosystems, Inc.|RPID - Real Price to Acquire Entire Company
- book capitalization data:
Book Price of a Share Rapid Micro Biosystems|RPID - Book Capitalization|Market Capitalization to Book Value rapidmicrobio.com|RPID - Company Total Assets
- debt obligations and liquidity statistics:
Total Debt to Equity Ratio Rapid Micro Biosystems|RPID - Long-Term Debt to Equity Ratio|Ratio of Short-Term Indebtedness to Capital Rapid Micro|RPID - Company Debts|Debt to Book Value Rapid Micro Biosystems, Inc.|RPID - Company Long-Term Debts|Short-Term Debt Rapid Micro Biosystems|Immediate Liquidity Ratio rapidmicrobio.com
- earnings and valuation multiples information:
RPID - Net Profit|Company Profit Forecast Rapid Micro Biosystems|RPID - P/E Multiple|Projected Price to Earnings Rapid Micro|RPID - PEG Multiple|EV/EBITDA Multiple Rapid Micro Biosystems, Inc.|RPID - Profit before payment of interest, taxes and amortization|Earnings per share for the last twelve months Rapid Micro Biosystems|RPID - Net earnings per share for the last 12 months|Year-over-year earnings per one share growth for the last 12 months rapidmicrobio.com|RPID - Earnings growth in current year|Expected net earnings per share growth next year Rapid Micro Biosystems
Comprehensive company analysis:RPID rapidmicrobio.com
Signature product of Rapid Micro Biosystems

The P/E ratio determines an asset's investment attractiveness by comparing market capitalization to net income. This metric measures the payback period for investments, assuming the issuer's income levels remain constant. By analyzing a company's P/E valuation, an investor identifies whether a business is overbought or undervalued. The fundamental stability of Rapid Micro Biosystems (RPID) is confirmed by the demand from pharma behemoths for robotic sterility systems that minimize production defects.

Key competitors

Market Cap to Earnings abbott.com ABT|Price to Earnings Ratio Thermo Fisher (TMO)|Business Payback Period GE HealthCare Technologies Inc.|Mettler-Toledo International Inc. - Price to Earnings Ratio|Market Price to Net Income Ratio WAT (Waters Technologies)|Bio-Techne Corporation - P/E Multiple|Business Payback Period bruker.com BRKR|AZTA: P/E Multiple|Price to Earnings Ratio Varex Imaging Corp|Price to Earnings Ratio SMLR|BFLY: Company Value to Net Income|Price to Earnings Ratio Mesa Laboratories, Inc. (MLAB)|Price to Earnings Ratio quantum-si.com QSI|P/E Multiple NNOX (Nano-X)|Quanterix Corp. (QTRX) - Market Cap to Earnings|908 Devices Corp - P/E Multiple|CV (CapsoVision Inc) - Price to Earnings Multiple|MXCT: P/E Multiple|SEER - Business Payback Period|HYPR (Hyperfine) - P/E Multiple|Price to Earnings Ratio FONAR Corp. (FONR)|P/E Multiple DXR|P/E Multiple spectral-ai.com (MDAI)|Price to Earnings Ratio VivoSim Labs Inc VIVS|aclarion.com - Price to Earnings Ratio|AKYA: Price to Earnings Ratio|Company Value to Net Income THMO (ThermoGenesis Holdings, Inc.)|TLIS: P/E Multiple|Market Cap to Earnings T2 Biosystems Inc (TTOO)